Crossref journal-article
Oxford University Press (OUP)
The Journal of Immunology (286)
Abstract

AbstractADP-ribosyltransferase-2 (ART2), a GPI-anchored, toxin-related ADP-ribosylating ectoenzyme, is prominently expressed by murine T cells but not by B cells. Upon exposure of T cells to NAD, the substrate for ADP-ribosylation, ART2 catalyzes ADP-ribosylation of the P2X7 purinoceptor and other functionally important cell surface proteins. This in turn activates P2X7 and induces exposure of phosphatidylserine and shedding of CD62L. CD38, a potent ecto-NAD-glycohydrolase, is strongly expressed by most B cells but only weakly by T cells. Following incubation with NAD, CD38-deficient splenocytes exhibited lower NAD-glycohydrolase activity and stronger ADP-ribosylation of cell surface proteins than their wild-type counterparts. Depletion of CD38high cells from wild-type splenocytes resulted in stronger ADP-ribosylation on the remaining cells. Similarly, treatment of total splenocytes with the CD38 inhibitor nicotinamide 2′-deoxy-2′-fluoroarabinoside adenine dinucleotide increased the level of cell surface ADP-ribosylation. Furthermore, the majority of T cells isolated from CD38-deficient mice “spontaneously” exposed phosphatidylserine and lacked CD62L, most likely reflecting previous encounter with ecto-NAD. Our findings support the notion that ecto-NAD functions as a signaling molecule following its release from cells by lytic or nonlytic mechanisms. ART2 can sense and translate the local concentration of ecto-NAD into corresponding levels of ADP-ribosylated cell surface proteins, whereas CD38 controls the level of cell surface protein ADP-ribosylation by limiting the substrate availability for ART2.

Bibliography

Krebs, C., Adriouch, S., Braasch, F., Koestner, W., Leiter, E. H., Seman, M., Lund, F. E., Oppenheimer, N., Haag, F., & Koch-Nolte, F. (2005). CD38 Controls ADP-Ribosyltransferase-2-Catalyzed ADP-Ribosylation of T Cell Surface Proteins. The Journal of Immunology, 174(6), 3298–3305.

Authors 10
  1. Christian Krebs (first)
  2. Sahil Adriouch (additional)
  3. Fenja Braasch (additional)
  4. Wolfgang Koestner (additional)
  5. Edward H. Leiter (additional)
  6. Michel Seman (additional)
  7. Frances E. Lund (additional)
  8. Norman Oppenheimer (additional)
  9. Friedrich Haag (additional)
  10. Friedrich Koch-Nolte (additional)
References 47 Referenced 75
  1. Corda, D., M. Di Girolamo. 2003. Functional aspects of protein mono-ADP-ribosylation. EMBO J. 22:1953. (10.1093/emboj/cdg209)
  2. Seman, M., S. Adriouch, F. Haag, F. Koch-Nolte. 2004. Ecto-ADP-ribosyltransferases (ARTs): emerging actors in cell communication and signaling. Curr. Med. Chem. 11:857. (10.2174/0929867043455611)
  3. Aktories, K., I. Just. 2000. Bacterial Protein Toxins Springer, Berlin. (10.1007/978-3-662-05971-5)
  4. Okazaki, I. J., H. J. Kim, N. G. McElvaney, E. Lesma, J. Moss. 1996. Molecular characterization of a glycosylphosphatidylinositol-linked ADP-ribosyltransferase from lymphocytes. Blood 88:915. (10.1182/blood.V88.3.915.bloodjournal883915)
  5. Glowacki, G., R. Braren, K. Firner, M. Nissen, M. Kuhl, P. Reche, F. Bazan, M. Cetkovic-Cvrlje, E. Leiter, F. Haag, F. Koch-Nolte. 2002. The family of toxin-related ecto-ADP-ribosyltransferases in humans and the mouse. Protein Sci. 11:1657. (10.1110/ps.0200602)
  6. Okamoto, S., O. Azhipa, Y. Yu, E. Russo, G. Dennert. 1998. Expression of ADP-ribosyltransferase on normal T lymphocytes and effects of nicotinamide adenine dinucleotide on their function. J. Immunol. 160:4190. (10.4049/jimmunol.160.9.4190)
  7. Seman, M., S. Adriouch, F. Scheuplein, C. Krebs, D. Freese, G. Glowacki, P. Deterre, F. Haag, F. Koch-Nolte. 2003. NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 19:571. (10.1016/S1074-7613(03)00266-8)
  8. Adriouch, S., W. Ohlrogge, F. Haag, F. Koch-Nolte, M. Seman. 2001. Rapid induction of naive T cell apoptosis by ecto-nicotinamide adenine dinucleotide: requirement for mono(ADP-ribosyl)transferase 2 and a downstream effector. J. Immunol. 167:196. (10.4049/jimmunol.167.1.196)
  9. Liu, Z. X., O. Azhipa, S. Okamoto, S. Govindarajan, G. Dennert. 2001. Extracellular nicotinamide adenine dinucleotide induces T cell apoptosis in vivo and in vitro. J. Immunol. 167:4942. (10.4049/jimmunol.167.9.4942)
  10. Bortell, R., J. Moss, R. C. McKenna, M. R. Rigby, D. Niedzwiecki, L. A. Stevens, W. A. Patton, J. P. Mordes, D. L. Greiner, A. A. Rossini. 2001. Nicotinamide adenine dinucleotide (NAD) and its metabolites inhibit T lymphocyte proliferation: role of cell surface NAD glycohydrolase and pyrophosphatase activities. J. Immunol. 167:2049. (10.4049/jimmunol.167.4.2049)
  11. Di Virgilio, F., P. Chiozzi, D. Ferrari, S. Falzoni, J. M. Sanz, A. Morelli, M. Torboli, G. Bolognesi, O. R. Baricordi. 2001. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97:587. (10.1182/blood.V97.3.587)
  12. North, R. A.. 2002. Molecular physiology of P2X receptors. Physiol. Rev. 82:1013. (10.1152/physrev.00015.2002)
  13. Surprenant, A., F. Rassendren, E. Kawashima, R. A. North, G. Buell. 1996. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272:735. (10.1126/science.272.5262.735)
  14. Zanovello, P., V. Bronte, A. Rosato, P. Pizzo, F. Di Virgilio. 1990. Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation. J. Immunol. 145:1545. (10.4049/jimmunol.145.5.1545)
  15. Jamieson, G. P., M. B. Snook, P. J. Thurlow, J. S. Wiley. 1996. Extracellular ATP causes of loss of L-selectin from human lymphocytes via occupancy of P2Z purinocepters. J. Cell. Physiol. 166:637. (10.1002/(SICI)1097-4652(199603)166:3<637::AID-JCP19>3.0.CO;2-3)
  16. Ohlrogge, W., F. Haag, J. Lohler, M. Seman, D. R. Littman, N. Killeen, F. Koch-Nolte. 2002. Generation and characterization of ecto-ADP-ribosyltransferase ART2.1/ART2.2-deficient mice. Mol. Cell. Biol. 22:7535. (10.1128/MCB.22.21.7535-7542.2002)
  17. Adriouch, S., C. Dox, V. Welge, M. Seman, F. Koch-Nolte, F. Haag. 2002. Cutting edge: a natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor. J. Immunol. 169:4108. (10.4049/jimmunol.169.8.4108)
  18. Ferrero, E., F. Malavasi. 1999. The metamorphosis of a molecule: from soluble enzyme to the leukocyte receptor CD38. J. Leukocyte Biol. 65:151. (10.1002/jlb.65.2.151)
  19. Schuber, F., F. E. Lund. 2004. Structure and enzymology of ADP-ribosyl cyclases: conserved enzymes that produce multiple calcium mobilizing metabolites. Curr. Mol. Med. 4:249. (10.2174/1566524043360708)
  20. Cockayne, D. A., T. Muchamuel, J. C. Grimaldi, H. Muller-Steffner, T. D. Randall, F. E. Lund, R. Murray, F. Schuber, M. C. Howard. 1998. Mice deficient for the ecto-nicotinamide adenine dinucleotide glycohydrolase CD38 exhibit altered humoral immune responses. Blood 92:1324. (10.1182/blood.V92.4.1324)
  21. Partida-Sanchez, S., D. A. Cockayne, S. Monard, E. L. Jacobson, N. Oppenheimer, B. Garvy, K. Kusser, S. Goodrich, M. Howard, A. Harmsen, et al 2001. Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo. Nat. Med. 7:1209. (10.1038/nm1101-1209)
  22. Partida-Sanchez, S., S. Goodrich, K. Kusser, N. Oppenheimer, T. D. Randall, F. E. Lund. 2004. Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity. Immunity 20:279. (10.1016/S1074-7613(04)00048-2)
  23. Ziegler, M.. 2000. New functions of a long-known molecule: emerging roles of NAD in cellular signaling. Eur. J. Biochem. 267:1550. (10.1046/j.1432-1327.2000.01187.x)
  24. la Sala, A., D. Ferrari, F. Di Virgilio, M. Idzko, J. Norgauer, G. Girolomoni. 2003. Alerting and tuning the immune response by extracellular nucleotides. J. Leukocyte Biol. 73:339. (10.1189/jlb.0802418)
  25. Berger, F., M. H. Ramirez-Hernandez, M. Ziegler. 2004. The new life of a centenarian: signalling functions of NAD(P). Trends Biochem. Sci. 29:111. (10.1016/j.tibs.2004.01.007)
  26. Bruzzone, S., L. Guida, E. Zocchi, L. Franco, A. De Flora. 2001. Connexin 43 hemi channels mediate Ca2+-regulated transmembrane NAD+ fluxes in intact cells. FASEB J. 15:10. (10.1096/fj.00-0566fje)
  27. Lazarowski, E. R., R. C. Boucher, T. K. Harden. 2003. Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol. Pharmacol. 64:785. (10.1124/mol.64.4.785)
  28. Zimmermann, H., N. Braun. 1999. Ecto-nucleotidases: molecular structures, catalytic properties, and functional roles in the nervous system. Prog. Brain Res. 120:371. (10.1016/S0079-6123(08)63570-0)
  29. Sneddon, P., T. D. Westfall, L. D. Todorov, S. Mihaylova-Todorova, D. P. Westfall, C. Kennedy. 1999. Modulation of purinergic neurotransmission. Prog. Brain Res. 120:11. (10.1016/S0079-6123(08)63542-6)
  30. Krebs, C., W. Koestner, M. Nissen, V. Welge, I. Parusel, F. Malavasi, E. H. Leiter, R. M. Santella, F. Haag, F. Koch-Nolte. 2003. Flow cytometric and immunoblot assays for cell surface ADP-ribosylation using a monoclonal antibody specific for ethenoadenosine. Anal. Biochem. 314:108. (10.1016/S0003-2697(02)00640-1)
  31. Muller-Steffner, H. M., O. Malver, L. Hosie, N. J. Oppenheimer, F. Schuber. 1992. Slow-binding inhibition of NAD+ glycohydrolase by arabino analogues of β-NAD. J. Biol. Chem. 267:9606. (10.1016/S0021-9258(19)50133-8)
  32. Koch-Nolte, F., T. Duffy, M. Nissen, S. Kahl, N. Killeen, V. Ablamunits, F. Haag, E. H. Leiter. 1999. A new monoclonal antibody detects a developmentally regulated mouse ecto-ADP-ribosyltransferase on T cells: subset distribution, inbred strain variation, and modulation upon T cell activation. J. Immunol. 163:6014.
  33. Kahl, S., M. Nissen, R. Girisch, T. Duffy, E. H. Leiter, F. Haag, F. Koch-Nolte. 2000. Metalloprotease-mediated shedding of enzymatically active mouse ecto-ADP-ribosyltransferase ART2.2 upon T cell activation. J. Immunol. 165:4463. (10.4049/jimmunol.165.8.4463)
  34. Moreno-Garcia, M. E., S. Partida-Sanchez, J. Primack, A. Sumoza-Toledo, H. Muller-Steffner, F. Schuber, N. Oppenheimer, F. E. Lund, L. Santos-Argumedo. 2004. CD38 is expressed as noncovalently associated homodimers on the surface of murine B lymphocytes. Eur. J. Biochem. 271:1025. (10.1111/j.1432-1033.2004.04006.x)
  35. Schweitzer, K., G. W. Mayr, A. H. Guse. 2001. Assay for ADP-ribosyl cyclase by reverse-phase high-performance liquid chromatography. Anal. Biochem. 299:218. (10.1006/abio.2001.5419)
  36. Koch-Nolte, F., D. Petersen, S. Balasubramanian, F. Haag, D. Kahlke, T. Willer, R. Kastelein, F. Bazan, H. G. Thiele. 1996. Mouse T cell membrane proteins Rt6–1 and Rt6–2 are arginine/protein mono(ADPribosyl)transferases and share secondary structure motifs with ADP-ribosylating bacterial toxins. J. Biol. Chem. 271:7686. (10.1074/jbc.271.13.7686)
  37. Deterre, P., L. Gelman, H. Gary-Gouy, C. Arrieumerlou, V. Berthelier, J. M. Tixier, S. Ktorza, J. Goding, C. Schmitt, G. Bismuth. 1996. Coordinated regulation in human T cells of nucleotide-hydrolyzing ecto-enzymatic activities, including CD38 and PC-1: possible role in the recycling of nicotinamide adenine dinucleotide metabolites. J. Immunol. 157:1381.
  38. Goding, J. W., M. C. Howard. 1998. Ecto-enzymes of lymphoid cells. Immunol. Rev. 161:5. (10.1111/j.1600-065X.1998.tb01567.x)
  39. Partida-Sanchez, S., P. Iribarren, M. E. Moreno-Garcia, J. L. Gao, P. M. Murphy, N. Oppenheimer, J. M. Wang, F. E. Lund. 2004. Chemotaxis and calcium responses of phagocytes to formyl peptide receptor ligands is differentially regulated by cyclic ADP ribose. J. Immunol. 172:1896. (10.4049/jimmunol.172.3.1896)
  40. Mitsui-Saito, M., I. Kato, S. Takasawa, H. Okamoto, T. Yanagisawa. 2003. CD38 gene disruption inhibits the contraction induced by α-adrenoceptor stimulation in mouse aorta. J. Vet. Med. Sci. 65:1325. (10.1292/jvms.65.1325)
  41. Kato, I., Y. Yamamoto, M. Fujimura, N. Noguchi, S. Takasawa, H. Okamoto. 1999. CD38 disruption impairs glucose-induced increases in cyclic ADP-ribose, [Ca2+]i, and insulin secretion. J. Biol. Chem. 274:1869. (10.1074/jbc.274.4.1869)
  42. Fukushi, Y., I. Kato, S. Takasawa, T. Sasaki, B. H. Ong, M. Sato, A. Ohsaga, K. Sato, K. Shirato, H. Okamoto, Y. Maruyama. 2001. Identification of cyclic ADP-ribose-dependent mechanisms in pancreatic muscarinic Ca2+ signaling using CD38 knockout mice. J. Biol. Chem. 276:649. (10.1074/jbc.M004469200)
  43. Jacobson, E. L., M. K. Jacobson. 1997. Tissue NAD as a biochemical measure of niacin status in humans. Methods Enzymol. 280:221. (10.1016/S0076-6879(97)80113-9)
  44. Reidl, J., S. Schlor, A. Kraiss, J. Schmidt-Brauns, G. Kemmer, E. Soleva. 2000. NADP and NAD utilization in Haemophilus influenzae. Mol. Microbiol. 35:1573. (10.1046/j.1365-2958.2000.01829.x)
  45. King, C., A. Ilic, K. Koelsch, N. Sarvetnick. 2004. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117:265. (10.1016/S0092-8674(04)00335-6)
  46. Takahashi, J., Y. Kagaya, I. Kato, J. Ohta, S. Isoyama, M. Miura, Y. Sugai, M. Hirose, Y. Wakayama, M. Ninomiya, et al 2003. Deficit of CD38/cyclic ADP-ribose is differentially compensated in hearts by gender. Biochem. Biophys. Res. Commun. 312:434. (10.1016/j.bbrc.2003.10.143)
  47. Zielinska, W., H. Barata, E. N. Chini. 2004. Metabolism of cyclic ADP-ribose: zinc is an endogenous modulator of the cyclase/NAD glycohydrolase ratio of a CD38-like enzyme from human seminal fluid. Life Sci. 74:1781. (10.1016/j.lfs.2003.08.033)
Dates
Type When
Created 11 years, 4 months ago (April 21, 2014, 10:13 p.m.)
Deposited 7 months, 4 weeks ago (Jan. 2, 2025, 1:03 p.m.)
Indexed 3 months, 2 weeks ago (May 16, 2025, 1:25 p.m.)
Issued 20 years, 5 months ago (March 15, 2005)
Published 20 years, 5 months ago (March 15, 2005)
Published Print 20 years, 5 months ago (March 15, 2005)
Funders 0

None

@article{Krebs_2005, title={CD38 Controls ADP-Ribosyltransferase-2-Catalyzed ADP-Ribosylation of T Cell Surface Proteins}, volume={174}, ISSN={1550-6606}, url={http://dx.doi.org/10.4049/jimmunol.174.6.3298}, DOI={10.4049/jimmunol.174.6.3298}, number={6}, journal={The Journal of Immunology}, publisher={Oxford University Press (OUP)}, author={Krebs, Christian and Adriouch, Sahil and Braasch, Fenja and Koestner, Wolfgang and Leiter, Edward H. and Seman, Michel and Lund, Frances E. and Oppenheimer, Norman and Haag, Friedrich and Koch-Nolte, Friedrich}, year={2005}, month=mar, pages={3298–3305} }